2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

CD40/CD40 Ligand Signal Controls Cytotoxic Ability of Natural Killer Cells After Invariant Natural Killer T Cell Stimulation.

H. Fukuda,¹ T. Hiai,¹ R. Ishii,¹ H. Katsumata,¹ T. Kanzawa,¹ S. Miyairi,¹ M. Ikemiyagi,¹ Y. Ishii,² M. Okumi,¹ K. Tanabe.¹
CD47 Blockade Reduces Ischemia/Reperfusion Injury in Donation After Cardiac Death Rat Kidney Transplantation.

X. Wang,¹ M. Xu,¹ J. Jia,¹ Z. Zhang,¹ J. Gaut,² G. Upadhya,¹ P. Manning,³ Y. Lin,¹ W. Chapman.¹
CD8+ TAb-supp Cells Are Key Inhibitors of Humoral Alloimmunity by Inhibiting CD4+TFH Cells and Killing Germinal Center B Cells.

J. Zimmerer, C. Avila, S. Elzein, B. Ringwald, R. Warren, G. Bumgardner.
CD8+ TAb-supp Cells Suppress the Production of Multiple Alloantibody Isotypes in Response to MHC-Mismatched Cellular and Vascularized Allografts.

J. Zimmerer, C. Avila, S. Elzein, B. Ringwald, G. Bumgardner.
Cell-Subset Diversity in Adipose Derived Regenerative Cells Used in Renal Ischemic Reperfusion Injury Treatment.

R. Lathan,¹ R. Ghita,^1,2 D. Hillyard,¹ P. Mark,^1,2 M. Clancy.^1,2
Center Volume Does Not Influence the Risk Associated with Using High DRI Donor Livers.

S. Black,¹ E. Beal,¹ K. Mumtaz,² D. Hayes Jr.,³ A. El-Hinnawi,¹ K. Washburn,¹ D. Tumin.⁴
Center-Level Differences in Outcomes Following High-KDPI Kidney Transplants.

L. Wu, A. Massie, X. Luo, M. Bowring, D. Segev.
Chagas Disease and Outcome in Kidney Transplant.

M. Taylor, A. Martinoia, S. Di PIetrantonio, M. Torres, H. Petrone.
Challenges for the Travelling Donor: Variability Between Donor Work-Up and Donor Surgery in the Canadian Kidney Paired Donation Program.

B. Reikie, T. Kroczak, T. McGregor.
Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race.

K. Soliman, A. Posadas Salas, D. Taber.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z